Kezar Life Sciences, Inc. (KZR:NASDAQ) closed at $7.29 on May 8, 2026, unchanged on the day. The stock trades 3.4% below its 52-week high of $7.55 and 106.3% above its 52-week low of $3.53. Kezar Life Sciences, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 22, 2025, KZR closed higher on 60 days (24%). Its best day was March 30, 2026 (+20.16%) and its worst was March 5, 2026 (-6.57%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 1 time.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
Find more stocks like KZR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.